Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;2(1):118.
Epub 2020 Sep 5.

The Role of the Microbiome in Cancer and the Development of Cancer Therapeutics

Kaitlyn C Belknap  1 , Andrea L Cote  1 , Colin M McGill  2 , Cheryl P Andam  1   3 , Brian M Barth  1
Affiliations

The Role of the Microbiome in Cancer and the Development of Cancer Therapeutics

Kaitlyn C Belknap et al. Int J Biopharm Sci. 2020 Sep.

Abstract

Cancer is caused by a compilation of hereditary and environmental factors. In the past decade, next-generation sequencing has revealed the extent to which the microbiome influences the maintenance of homeostasis and therefore the prevention of diseases such as cancer. Current research efforts explore the interaction between cancer and the microbiome, and the results are anticipated to transform how clinicians approach cancer treatment. There is a plausible transition from the use of human genetic biomarkers to microbiomic biomarkers for genomic diagnostics. Considering the expanding knowledge of the ways in which the microbiome can affect the development of cancer, clinicians treating cancer patients should be considerate of how the microbiome can influence the host-drug or microbiome-cancer interactions. Recognition of the importance of the microbiome within the field of oncology is pertinent to understanding and furthering cancer development and treatment.

Keywords: breast cancer; cancer therapeutics; colorectal cancer; gastric cancer; leukemia; microbiome; skin cancer.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Kutschera U Systems biology of eukaryotic superorganisms and the holobiont concept. Theory Biosci. (2018); 137(2):117–131. - PubMed
    1. Guerrero R, Margulis L, Berlanga M Symbiogenesis: the holobiont as a unit of evolution. Int Microbiol. (2013); 16(3):133–143. - PubMed
    1. Sheflin AM, Whitney AK, Weir TL Cancer-promoting effects of microbial dysbiosis. Curr Oncol Rep. (2014); 16(10):406. - PMC - PubMed
    1. Samet A, Śledzińska A, Krawczyk B, Hellmann A, Nowicki S, et al. Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream. Eur J Clin Microbiol Infect Dis. (2013); 32(11):1393–1400. - PMC - PubMed
    1. Costa-Lima C, De Paula EV ‘Leaky gut’ in hematological malignancies. Rev Bras Hematol Hemoter. (2014); 36(6):390–391. - PMC - PubMed

LinkOut - more resources